| PERIOD ENDING | 31-Mar-09 | 30-Sep-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 20,458,000 | 898,000 | 19,933,000 | 14,031,000 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 20,458,000 | 898,000 | 19,933,000 | 14,031,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,619,000 | 24,181,000 | 28,689,000 | 25,295,000 | | Non Recurring | 362,000 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,523,000) | (23,283,000) | (8,756,000) | (11,264,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,523,000) | (23,283,000) | (8,756,000) | (11,264,000) | | Interest Expense | 2,845,000 | 4,902,000 |
-
|
-
| | Income Before Tax | (6,368,000) | (28,185,000) | (8,756,000) | (11,264,000) | | Income Tax Expense | (1,235,000) | (3,480,000) | (3,357,000) | (3,537,000) | | Minority Interest |
-
| 237,000 | 42,000 | (78,000) | | | | Net Income From Continuing Ops | (5,133,000) | (24,468,000) | (5,357,000) | (7,805,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,133,000) | (24,468,000) | (5,357,000) | (7,805,000) | | Preferred Stock And Other Adjustments | 780,000 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,353,000) | ($24,468,000) | ($5,357,000) | ($7,805,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
